Cargando…
Vasopressin in vasodilatory shock: is the heart in danger?
In patients with hyperdynamic hemodynamics, infusing arginine vasopressin (AVP) in advanced vasodilatory shock is usually accompanied by a decrease in cardiac output and in visceral organ blood flow. Depending on the infusion rate, this vasoconstriction also reduces coronary blood flow despite an in...
Autores principales: | Hauser, Balázs, Asfar, Pierre, Calzia, Enrico, Laporte, Régent, Georgieff, Michael, Radermacher, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2447576/ https://www.ncbi.nlm.nih.gov/pubmed/18423065 http://dx.doi.org/10.1186/cc6839 |
Ejemplares similares
-
Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
por: Bracht, Hendrik, et al.
Publicado: (2007) -
Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial
por: Simon, Florian, et al.
Publicado: (2009) -
Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart!
por: Dünser, Martin W, et al.
Publicado: (2006) -
Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?
por: Asfar, Pierre, et al.
Publicado: (2009) -
Epinephrine kinetics in septic shock – a means to understand variable catecholamine efficiency?
por: Calzia, Enrico, et al.
Publicado: (2009)